FIELD: medicine.
SUBSTANCE: treating psoriasis in children is ensured by the pulmonary administration of 0.025% Thymodepressin in dosage 0.5 ml per one inhalation. The therapeutic course makes 10 to 15 procedures. The intrabronchial administration is ensured by using an apparatus to transform a drug preparation into a fine nebulous dosage form.
EFFECT: higher clinical effectiveness for psoriasis in children; the method is noninvasive and effective when used in a single agent therapy.
3 ex
Title | Year | Author | Number |
---|---|---|---|
OINTMENT FOR TREATING PSORIASIS (VERSIONS) | 2018 |
|
RU2705162C1 |
METHOD FOR TREATING PSORIASIS | 1998 |
|
RU2190406C2 |
METHOD OF TREATMENT OF PSORIASIS | 2017 |
|
RU2666290C1 |
METHOD OF TREATMENT OF PSORIASIS | 2005 |
|
RU2302193C1 |
METHOD OF PSORIASIS TREATMENT | 2008 |
|
RU2386412C1 |
METHOD FOR TREATING PSORIASIS | 2006 |
|
RU2322255C1 |
METHOD FOR PSORIASIS TREATMENT | 0 |
|
SU1796197A1 |
OINTMENT FOR PSORIASIS TREATMENT | 1995 |
|
RU2091065C1 |
METHOD OF TREATING PSORIASIS | 2009 |
|
RU2393840C1 |
REMEDY FOR PSORIASIS TREATMENT | 1990 |
|
RU2017488C1 |
Authors
Dates
2010-10-10—Published
2006-06-13—Filed